Muthukumaran Sivanandham1, Eugene M Kim, Marc K Wallack
1Department of Surgery, Saint Vincent's Hospital & Medical Center of New York/New York, Medical College, 153 West 12th Street, New York, NY 10011, USA. msivanandham@compuserve.com
Melanoma vaccines, including antigen-based and vector-based approaches, show promise in clinical trials. Some melanoma vaccines have demonstrated improved survival rates and are progressing to phase III trials for potential standard care.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: